Ningbo Menovo Pharmaceutical (603538.SH) released the 2024 interim report, reporting a revenue of 6....
Zhixun Finance APP news, Ningbo Menovo Pharmaceutical (603538.SH) released the 2024 interim report, reporting a revenue of 0.608 billion yuan, a 4.40% year-on-year increase; net income attributable to shareholders of the listed company was 18.9425 million yuan, a 38.61% year-on-year decrease; net income attributable to shareholders of the listed company excluding non-recurring gains and losses was 19.6562 million yuan, a 23.64% year-on-year decrease; basic earnings per share was 0.09 yuan/share.